Home › Aerocrine Resumes Sales and Marketing of Niox Mino in China after Re-Registration Approval
 

Keywords :   


Aerocrine Resumes Sales and Marketing of Niox Mino in China after Re-Registration Approval

2014-12-15 11:14:35| Appliances - Topix.net

Aerocrine AB , a leader in products to monitor and manage airway inflammation associated with Asthma, announced today that its handheld airway inflammation monitoring device, NIOX MINO, has been re-registered for marketing and sales by the China Food and Drug Administration . The approval means that Aerocrine and its partners can now resume its sales and marketing activities of NIOX MINO and grow the deployed base in the Chinese market.

Tags: sales china marketing approval

Category:Consumer Goods and Services

Latest from this category

All news
09.10Budget plan to spend billions more wont stop tax rises
09.10Post Office boss 'told not to dig into' Horizon issues
09.10IRIS.TV partners with Samba TV on contextual advertising and measurement
09.10I am not Bitcoin inventor, says man named in HBO film
09.10Parrot Analytics launches global Streaming Metrics
09.10SEI Robotics and Dish TV launch 'Dish TV Smart+ Box'
09.107-Eleven shares jump as rival makes new buyout offer
09.10Nuclear plant 'will decimate fish stocks'
Consumer Goods and Services »
09.10Hurricane Milton Public Advisory Number 18A
09.10Atlantic Tropical Weather Outlook
09.10Eastern North Pacific Tropical Weather Outlook
09.10Schreiner Group names Ken Forlenza US president
09.10Intake variation affects performance and feed efficiency of finishing beef cattle
09.10Hurricane Milton Update Statement
09.10Summary for Hurricane Milton (AT4/AL142024)
09.10INX earns Great Place to Work recertification
More »